mo:re GmbH
Hamburg
About mo:re GmbH
Mo:re is building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: more.science
- Phone: +49 40 23834412
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Robotics
Social Profiles
Canonical: https://fsome.com/organization/mo-re-gmbh-43518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.